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The newly discovered cytokine interleukin-20 (IL-20) is
structurally related to IL-10, yet it appears to be an
autocrine factor for keratinocytes that regulates their
participation in inflammation.
Address: Harvard Skin Disease Research Center, Brigham and
Women’s Hospital, 77 Avenue Louis Pasteur, Boston, Massachusetts
02115, USA.
E-mail: brich@rics.bwh.harvard.edu
Current Biology 2001, 11:R531–R534
0960-9822/01/$ – see front matter 
© 2001 Elsevier Science Ltd. All rights reserved.
As the DNA sequences of mammalian chromosomes and
vast cDNA libraries become available, researchers are vigor-
ously scouring them for their favorite genes. The search for
new cytokines has been among the most competitive and
indeed one of the latest finds, interleukin-20 (IL-20), was
discovered in silico. Using a computational method to iden-
tify sequences encoding amphipathic α helices as well as a
signal peptide, Blumberg et al. [1] focused on a high-scoring
cDNA from a keratinocyte library. This cDNA was found to
encode a relative of the cytokine IL-10 and was named
IL-20. Biological studies of IL-20 revealed that it has an
important role in promoting hyperproliferation of ker-
atinocytes and thereby modulating inflammation in the skin.
A new member of the IL-10 family
The IL-20 mRNA contains motifs in its 3′ untranslated
region that are associated with instability. In agreement
with this, the IL-20 mRNA appears to be rare and short-
lived. The polypeptide sequence of IL-20 is similar
(20–40% identical) to that of IL-10 and four other mam-
malian cytokines, as well as several viral products that con-
stitute the IL-10 family (Table 1). The presence of IL-10-
related genes in various viral genomes may reflect the
ability of these factors to act as autocrine growth factors for
infected cells as well as regulatory signals to parry host
immune responses. Further application of sensitive algo-
rithms to the complete sequences of the human and other
mammalian genomes is likely to identify any remaining
members of this family (as well as other cytokine families)
in the near future.
The genes encoding the known human IL-10-related
cytokines are clustered in two loci. The genes for IL-10,
IL-19, IL-20 and the melanocyte differentiation-associ-
ated factor MDA-7 are found within a 200 kb region of
chromosome 1, whereas genes encoding the two other
family members — IL-22 and AK155 (a factor induced
upon transformation by Herpesvirus) — are found within
30 kb of each other and less than 100 kb from the inter-
feron-γ (IFN-γ) gene on chromosome 12. Certain alleles of
this region of chromosome 12 have been found to be asso-
ciated with asthma and inflammatory bowel disease [2].
While initial attention was drawn to the IFN-γ gene, allelic
variants have not been found. Therefore it remains possi-
ble that variations in either the IL-22 or AK155 genes con-
tribute to these diseases. 
Transgenic mice reveal skin as a major target of IL-20
To investigate the biology of IL-20 in vivo, several trans-
genic mice were generated that expressed IL-20 under the
control of various tissue-specific promoters. All of these
mice were runted at birth and died within days. Histologi-
cal analysis revealed a profoundly thickened epidermis
characterized by increased numbers of keratinocytes and
expression in the suprabasal layers of differentiation and
proliferation markers that are normally confined to the
basal layer. These changes appeared to be caused by circu-
lating IL-20, because even mice expressing the transgene
in tissues away from the skin, such as in the liver (driven
by the albumin promoter), were similarly affected.
In light of the effects of IL-20 on the epidermis of the trans-
genic mice, Blumberg et al. [1] focused their attention on
keratinocytes. IL-20 was found to activate signal transducer
and activator of transcription 3 (Stat3), one of the transcrip-
tional activators involved in IL-10 signaling, in an immortal-
ized keratinocyte cell line (HaCaT). Exposure of HaCaT
cells to IL-20 induces translocation of Stat3 to the nucleus
and stimulation of transcription from a Stat3-responsive
reporter gene. Stat3 can be activated by more than a dozen
different factors in different cell types. Its central role in
development is demonstrated by the observation that Stat3-
deficient mice die as early embryos. Specific deletion of the
Stat3 gene in keratinocytes blocks their responses to epider-
mal growth factor (EGF), hepatocyte growth factor (HGF)
and IL-6 [3]. Although Stat3-deficient keratinocytes can
form approximately normal skin, they are defective in
wound healing and have altered secondary hair cycles.
While EGF is an important cytokine for keratinocytes,
some of the deficits in Stat3-deficient keratinocytes may
also be due to their inability to respond to IL-20, given the
recent study by Blumberg et al. [1]. In addition, as IL-10
signal transduction includes both Stat3-dependent and
-independent pathways, it is possible, by analogy, that
IL-20 signal transduction is similarly complex [4].
When HaCaT cells were incubated with IL-20 in the pres-
ence of submaximal concentrations of IL-1β, tumor necro-
sis factor α (TNF-α) or EGF, strong cooperativity was
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observed, increasing their sensitivity to IL-20 by as much
as 10-fold and quadrupling the magnitude of their response.
Three genes found to be upregulated by IL-20 in HaCaT
cells encode proteins involved in inflammation: TNF-α,
which is likely to further enhance the response of ker-
atinocytes to IL-20 and also stimulates chemotaxis and
antimicrobial activity of myeloid cells; the chemokine
MCP-1, involved in leukocyte chemotaxis; and MRP-14,
one of the S100 calcium-binding proteins implicated in
neutrophil integrin activation and associated with epider-
mal inflammation [5].
The IL-20 receptor is upregulated in psoriasis
Receptor chains expressed in HaCaT cells were examined
and two previously known but orphan class II cytokine
receptor chains (now named IL-20Rα and IL-20Rβ) were
found to form a functional cognate receptor for IL-20
when co-transfected into a different cell line. Because
suprabasal expression of basal keratins and proliferation
markers, as well as certain structural alterations in the epi-
dermis of the IL-20 transgenic mice are similar to features
of psoriasis, expression of the two receptor chains was
measured in normal and psoriatic human skin. While very
low levels were detected in normal skin, dramatic induc-
tion of both chains was found in keratinocytes, endothelial
cells and certain mononuclear cells in psoriatic lesions.
The hyperproliferation of keratinocytes associated with
psoriasis is dependent upon the participation of activated
T cells [6]; IFN-γ, normally a product of activated T cells,
provokes similar hyperproliferation of keratinocytes [7].
Therefore it seems likely that expression of the IL-20
receptor, and perhaps IL-20, by keratinocytes is stimu-
lated by IFN-γ or other products of activated T cells.
Whether in concert with other factors or expressed by
Table 1
The IL-10 family of cytokines.
Cytokine Gene location Cellular source Cognate receptor Biological activities References
IL-10 Human 1q32 Activated T cells, B cells, IL-10Rα, IL-10Rβ Enhances Th2 differentiation; [9]
monocytes, keratinocytes suppresses Th1 differentiation
IL-19 Human 1q32 Stimulated monocytes Unknown: not IL-10Rα, Unknown [10]
IL-10Rβ
IL-20 Human 1q32 cDNA found in a keratinocyte IL-20Rα, IL-20Rβ; Stimulates keratinocyte [1]
library both upregulated in proliferation and differentiation;
psoriasis activates Stat3; receptor also 
on certain endothelial and 
mononuclear cells
MDA-7 Human 1q32 Melanocytes, stimulated cells, Binding activity Expression associated with [11–13]
(mob-5, C49a) melanoma cells, fibroblasts in detected on differentiation of melanocytes; 
wound repair, ras-transformed ras-transformed cells reverts malignant phenotype 
cells of melanoma; upregulated in 
wound healing; autocrine factor 
of ras-transformed cells 
IL-22 (IL-TIF) Human 12q15 IL-9- or lectin-stimulated T cells, IL-22Rα, IL-10Rβ Activates Stat1, 3, 5; [14–16]
mast cells stimulates monocytes to 
make TNF
AK155 Human 12q15 Herpesvirus saimiri transformed Unknown Transformation of T cells? [17]
T cells
ebvIL-10 Epstein–Barr virus (EBV) EBV-infected cells IL-10Rα, IL-10Rβ Similar to IL-10 but lower affinity; [18,19]
(BCRF1) genome may block immune response to 
viral infected cells; autocrine growth 
factor for infected B cells.
cmvIL-10 Cytomegalovirus (CMV) CMV-infected cells IL-10Rα, IL-10Rβ Similar to IL-10, may block immune [20]
genome response to virus-infected cells
hpvIL-10 Herpesvirus papio Unknown Unknown Unknown Genbank
genome accession
AAF23949
yldvIL-10 Yaba-like disease Unknown Unknown Unknown Genbank 
virus genome accession
NP_073519
itself, IL-20 exerts distinctly proinflammatory effects on
keratinocytes and may play a central role in the epidermal
response to inflammation. 
Two functions of the epidermis
When investigating the role of cytokines in the epidermis,
we must consider that skin has two fundamental functions:
first, it provides a self-repairing physical barrier to keep the
rest of the organism in and the outside world out, and
second, it acts as a dynamic environment for the front line of
the immune system to encounter and respond to pathogens.
These two functions act in concert to protect the organism
from the environment. Figure 1 illustrates some of the sig-
naling pathways involving the epidermis. Several different
circumstances can lead to changes in the homeostasis of the
epidermis and structural perturbations. Some phenomena
such as physical trauma, ultraviolet radiation or bacterial
lipopolysaccharide have direct effects on keratinocytes
and underlying fibroblasts, triggering the innate immune
system, whereas others such as antigenic challenges are
mediated by cells of the acquired immune system. 
Differentiation vs proliferation in the epidermis
The outermost layer of skin, the epidermis, consists of
layers of keratinocytes stratified in a gradient of differenti-
ation (Figure 1). Keratinocytes progress through a program
of differentiation as they move up through the skin to
become corneocytes, dead bundles of precipitated keratin
proteins wrapped in remnants of plasma membrane.
These protein ‘bricks’ and lipid ‘mortar’ form the barrier
of the skin called the stratum corneum. While cornified
cells are continually sloughed off, the less-differentiated
keratinocytes of the innermost basal layer of the epidermis
proliferate and differentiate as they are forced upwards,
continually reforming the barrier. Consequently, the struc-
ture of the epidermis is exquisitely dependent upon the
homeostatic balance between proliferation and differentia-














































Signaling pathways in inflammation of the skin. Basal layers of
keratinocytes proliferate while upper levels differentiate to form the
barrier. Changes in proliferation and differentiation alter the structure of
the skin. External stimuli such as trauma or irradiation cause keratinocytes
to release primary cytokines, IL-1α and TNF-α. These factors provoke
fibroblasts, leukocytes and keratinocytes to express more primary
cytokines (IL-1) as well as proinflammatory secondary cytokines and
chemokines. Trauma also elicits KGF and activin expression which
promote repair. Foreign antigens are captured by Langerhan's cells (LC)
and other antigen-presenting cells (APC) which migrate and interact with
T cells. Activated T cells, supported by secondary cytokines from the
epidermis, dermis and leukocytes, proliferate and release cytokines that
promote cellular (Th1, involving IFN-γ) or humoral (Th2, involving IL-4)
immune responses. Signals that control IL-20 expression are unknown,
however IL-20 receptor is upregulated in psoriatic epidermis, as well as
some leukocytes and endothelial cells.
epidermis. One of the keys to understanding the biology
of the skin is deciphering the molecular events that influ-
ence the keratinocytes’ decision between proliferation and
differentiation. Signals originating in the dermis, including
keratinocyte growth factor, are amplified by induced
expression of activin, and alter this balance during wound
repair and development [8]. IL-20 appears to be a signal
originating in the epidermis that directly impacts this deci-
sion in the context of inflammation.
Activation of keratinocytes
In addition to altering the balance between proliferation
and differentiation, keratinocytes participate in immune
responses by releasing signaling molecules. The ability of
keratinocytes to release complex arrays of proinflammatory
factors when provoked by stimuli such as physical trauma,
ultraviolet irradiation, bacterial products or cytokines
allows them to recruit inflammatory cells and regulate their
behavior. Factors released by keratinocytes in response to
various stimuli include TNF-α, IL-1α, IL-3, IL-6, IL-7,
IL-8, IL-10, TGF-α, TGF-β, IFN-γ and MCP-1 among
others. It is not clear whether these are products of a
single type of keratinocyte activation or derive from
several qualitatively different responses. In either case,
these factors convey signals in a paracrine fashion to other
cells including leukocytes, endothelial cells and fibrob-
lasts as well as in an autocrine fashion to the keratinocytes
themselves. Two prominent autocrine factors for ker-
atinocytes, TNF-α and IL-1α, are termed primary cytokines
because they activate the NFκB pathway, stimulating
transcription of a number of proinflammatory cytokines,
chemokines, adhesion molecules and other effectors in
many cell types. 
The biology of IL-20 must be viewed within the context
of this already crowded milieu of intercellular signals
involved with cutaneous inflammation and homeostasis.
Among these signals, however, there is no clear pathway
by which activated T cells can trigger the release of primary
cytokines by keratinocytes and the ensuing cascade of
proinflammatory events in the skin. The prominent expres-
sion of the IL-20 receptor in psoriatic skin hints that IL-20
expression may be an important step in this process.
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